Literature DB >> 10190563

Overexpression of midkine in lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats and its increase with progression.

H Sakitani1, M Tsutsumi, K Kadomatsu, S Ikematsu, M Takahama, K Iki, T Tsujiuchi, T Muramatsu, S Sakuma, T Sakaki, Y Konishi.   

Abstract

The expression of midkine (MK) in lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine (BHP) in rats was examined. The animals were administered 2000 p.p.m. of BHP in their drinking water for 12 weeks, then maintained without further treatment until being killed 20-28 weeks after the beginning of the experiment. MK mRNA expression of adenocarcinomas and squamous cell carcinomas assessed by means of the reverse transcriptase-polymerase chain reaction and northern blot analysis was significantly higher than in rat embryonic tissues (positive controls) and contrasted strongly with the lack in normal lungs. MK protein was detected immunohistochemically in 58.3% of alveolar hyperplasias, 92.3% of adenomas and 100% of adenocarcinomas and squamous cell carcinomas. The extent of staining significantly increased along with malignant progression in adenomatous (pre-)neoplastic lesions and tended to become more pronounced with malignant progression in squamous lesions. The results suggest that MK may play some essential roles in the development and progression of lung tumors induced by BHP in rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190563     DOI: 10.1093/carcin/20.3.465

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Protein-bound carbohydrates on cell-surface as targets of recognition: an odyssey in understanding them.

Authors:  T Muramatsu
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Implication of p16 inactivation in tumorigenic activity of respiratory epithelial cell lines and adenocarcinoma cell line established from plutonium-induced lung tumor in rat.

Authors:  Yutaka Yamada; Akifumi Nakata; Mitsuaki A Yoshida; Yoshiya Shimada; Yoichi Oghiso; Jean-Luc Poncy
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-05       Impact factor: 2.416

3.  Expression of midkine and its clinical significance in esophageal squamous cell carcinoma.

Authors:  Ying-Jia Ren; Qing-Yun Zhang
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

4.  ERβ-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine.

Authors:  Guangfeng Zhao; Yunzhong Nie; Mingming Lv; Lingfang He; Tingting Wang; Yayi Hou
Journal:  Mol Endocrinol       Date:  2012-06-05

Review 5.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.

Authors:  T Tsujiuchi; Y Sasaki; M Tsutsumi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2000-10

7.  Overexpression of midkine in pancreatic duct adenocarcinomas induced by N-Nitrosobis(2-oxopropyl)amine in hamsters and their cell lines.

Authors:  M Tsutsumi; K Kadomatsu; T Tsujiuchi; H Sakitani; S Ikematsu; T Kubozoe; M Yoshimoto; T Muramatsu; S Sakuma; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2000-10

8.  Clinical significance of midkine expression in pancreatic head carcinoma.

Authors:  S Maeda; H Shinchi; H Kurahara; Y Mataki; H Noma; K Maemura; K Aridome; T Yokomine; S Natsugoe; T Aikou; S Takao
Journal:  Br J Cancer       Date:  2007-07-10       Impact factor: 7.640

9.  Influence of Menopause on Inflammatory Cytokines during Murine and Human Bone Fracture Healing.

Authors:  Verena Fischer; Miriam Kalbitz; Fabian Müller-Graf; Florian Gebhard; Anita Ignatius; Astrid Liedert; Melanie Haffner-Luntzer
Journal:  Int J Mol Sci       Date:  2018-07-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.